This study investigates early-stage left-sided pancreatic cancer. The purpose of this study is to compare two surgical methods for treating this condition.
Researchers will evaluate the perioperative and oncological outcomes of these surgical methods. The study focuses on understanding the effectiveness and safety of these procedures.
- Who can participate: Adults with resectable left-sided pancreatic cancer, tumor diameter of 4 cm or less, and located at least 1 cm from the celiac trunk may participate. Participants must not have received neoadjuvant therapy or have distant metastasis.
- Study details: Participants will undergo either laparoscopic radical antegrade modular pancreatosplenectomy or laparoscopic distal pancreatosplenectomy and will be monitored for surgical outcomes and recovery.
How understandable was the trial content above?
Hard to understand
Easy to understand